Ositab is one of the recommended brands in the oncology division that manage the EGFR mutated NSCLC (Non-small cell lung cancer) in patients who have already progressed on or after taking EGFR TKI therapy. It comes in two dose forms and is prescribed accordingly based on the clinical condition of the patient. Click on the appropriate link below to view more details like uses, composition, and description of the products.
Resmetirom is an oral, first, liver-directed, selective thyroid hormone receptor - beta (THR-β) agonist approved by US FDA for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
To order or to know more details about Menthopas, reach us by filling the form. We will get back you within 1-2 business days.
Plot Nos. M-22 & M-25; Motanga Industrial Park, S/Jongkhar, Bhutan
Plot Nos. M-22 & M-25; Motanga Industrial Park, S/Jongkhar, Bhutan
